This article was first published 20 years ago

Dr Reddy's gets USFDA nod for glimepiride

google preferred source
Hyderabad based Dr Reddy's Laboratories has received approval from the US Food and Drugs Administration for multiple strengths of anti-diabetes drug glimepiride tablets.

According to information available on the USFDA website, glimeperide is available in stengths of 1 mg, 2 mg and 4 mg. The drug is a generic version of Sanofi-Aventis' Amaryl.

Dr Reddy's has also recieved tentative approval from the USFDA for anti-cholesterol drug pravastatin sodium tablets in multiple strengths. The drug is a generic version of Bristol-Myers Squibb Co's Pravachol.

Moneywiz Live!